During a Case-Based Roundtable® event, Matthew Campbell, MD, MS, moderated a discussion on treatment for a 61-year-old ...

Fred Hutch Cancer Center brought together a host of experts on November 2 to share tips, tools, resources and strategies for ...

Median overall survival (OS) increased from 19.3 months with upfront immune checkpoint inhibition (ICI) to 41.3 months when a ...

Ewing sarcoma (EWS) is a highly metastatic form of sarcoma, originating in bone with a peak incidence at the age of 15, that ranks as the second most prevalent primary malignant tumor of childhood and ...

The average time from consultation to treatment for bone metastases decreased by almost 4 days with virtual simulation ...

The best bone conduction headphones use vibrations on your cheekbones to recreate sound, leaving your ears open, boosting awareness of your surroundings and offering a more comfortable experience ...

Within this disease, bone metastasis (BM) emerges as a particularly deleterious site of metastatic dissemination, marked by a dismal prognosis. The objective of this investigation is to shed light on ...

or metastatic cervical cancer. The study enrolled 445 eligible Asian participants, with a median age of 56 years. Notably, 370 (83%) participants had squamous cell carcinoma, 215 (48%) had received ...

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP) Eligible patients were ...

The phase I clinical trial continues, and the researchers plan to investigate TYRA-300 in metastatic bladder cancer, non-muscle invasive bladder cancer, as well as abnormalities in bone growth ...

This Research Topic is part of a series of: https://www.frontiersin.org/research-topics/36924/pharmacological-mechanisms-of-drugs-affecting-bone-formation-and-bone ...